On March 5, 2025, Replimune Group, Inc. appointed Michael Goller to its Board of Directors and entered into a registration rights agreement with BBA Funds, allowing them to register shares for resale. Goller will receive an annual cash retainer of $45,000 and stock options for 64,000 shares at an exercise price of $12.29.